🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of Tylenol, alleging the firms withheld safety concerns that the drug created to children's brain development.

The lawsuit comes thirty days after Former President Trump publicized an unsubstantiated connection between using acetaminophen - also known as paracetamol - while pregnant and autism spectrum disorder in young ones.

The attorney general is suing Johnson & Johnson, which once produced the drug, the exclusive pain medication approved for pregnant women, and the current manufacturer, which presently makes it.

In a declaration, he said they "misled consumers by profiting off of pain and promoting medication without regard for the dangers."

The company says there is insufficient reliable data linking Tylenol to autism.

"These manufacturers misled for generations, knowingly endangering millions to line their pockets," Paxton, from the Republican party, stated.

The manufacturer said in a statement that it was "very worried by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its online platform, Kenvue also stated it had "regularly reviewed the applicable studies and there is insufficient valid information that demonstrates a verified association between taking paracetamol and autism spectrum disorder."

Organizations representing medical professionals and health professionals share this view.

The leading OB-GYN organization has said acetaminophen - the main ingredient in acetaminophen - is among limited choices for pregnant women to manage pain and fever, which can present major wellness concerns if ignored.

"In over twenty years of investigation on the consumption of paracetamol in gestation, not a single reputable study has conclusively proven that the consumption of paracetamol in any period of gestation leads to brain development issues in offspring," the group commented.

This legal action mentions latest statements from the former administration in claiming the medication is reportedly hazardous.

In recent weeks, the former president generated worry from medical authorities when he instructed women during pregnancy to "struggle intensely" not to use acetaminophen when unwell.

Federal regulators then published an announcement that doctors should consider limiting the usage of acetaminophen, while also stating that "a causal relationship" between the medication and autism spectrum disorder in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had pledged in April to initiate "extensive scientific investigation" that would establish the origin of autism spectrum disorder in a short period.

But authorities warned that identifying a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a complicated interplay of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and condition that affects how persons experience and interact with the surroundings, and is recognized using physician assessments.

In his legal document, Paxton - a Trump ally who is seeking federal office - asserts Kenvue and Johnson & Johnson "intentionally overlooked and sought to suppress the evidence" around acetaminophen and autism.

The lawsuit aims to force the firms "destroy any commercial messaging" that states Tylenol is reliable for women during pregnancy.

The court case mirrors the concerns of a assembly of mothers and fathers of children with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in two years ago.

The court rejected the legal action, saying research from the family's specialists was lacking definitive proof.